Events
New and improved Eyes On Career Fair to launch in January
Virtual event offers 4th-year optometry students and recent grads exclusive resources, job opportunities, and expert guidance for kickstarting their professional careers.
Pipeline
FDA clears Zhongmou Therapeutics' IND for RP optogenetic gene therapy
Clearance of ZM-02 marks the first optogenetic gene therapy originating from China to receive U.S. IND authorization.
Research
Research finds limited benefits of outdoor exposure for premyopic children
Protective effect of time outdoors observed in hyperopes and premyopic children after spending >120 minutes/day outside.
Research
CLI publishes full report on generational contact lens and eyewear preferences
Comprehensive research evaluates how Gen X, Millennial, and Gen Z consumers evaluate and interact with eyecare providers, practices, and products.
Business
Bausch + Lomb and Ripple Therapeutics partner to develop sustained-release implants
Collaboration involves the Epidel prodrug platform, which engineers polymer-free drugs with customized, repeat doses and durations for ophthalmic diseases.
Pipeline
Belite Bio reports phase 3 topline data on oral tinlarebant for Stargardt disease
DRAGON study is evaluating the once-daily tablet for reducing lesion growth among adolescent patients over a 24-month period.
Products
Amneal receives FDA approval for Restasis generic
Generic version of Allergan’s cyclosporine ophthalmic emulsion 0.05% eye drop for dry eye is the second to receive U.S. regulatory clearance.
Research
Deep learning-based software establishes new MGD imaging analysis
OASIS reduced the time required to analyze meibomian glands by 87%, highlighting its potential clinical utility.
Pipeline
Precise Bio performs first transplant with 3D-printed cornea implant
Procedure deemed successful in treating first fully blind patient using corneal bio-implant made from corneal endothelial cells.
Research
Could waist size determine DR risk?
Study demonstrates the potential of using weight-adjusted waist index to predict the risk of diabetic retinopathy.
Products
Evoq launches FDA-registered dark adaptation testing device for IRDs
The Twilight is a wearable and smartphone-based diagnostic tool for at-home, remote monitoring of retinal health and early retinal disease detection.
Pipeline
First autofocus glasses offer lightweight vision correction
New prototype design for prescription-based smart eyewear could be an alternative to traditional progressive lenses.
Pipeline
Ocuvex resubmits FDA CRL for brimonidine tartrate 0.35% NDA
Shared by partner SPARC, update follows 2+ years after the 2022 submission of investigational OAG and OHT eye drop was rejected in July 2023.
Research
Analysis: Global DR cases on the rise, sparking urgent need for intervention
Study highlights concerning global, regional, and national trends in DR-related blindness.
Products
FDA approves new EYLEA HD indication, expanded dosing intervals
Intravitreally-administered 2 mg aflibercept therapeutic is now cleared for macular edema following retinal vein occlusion.
Research
Eye blinks naturally keep tempo with music, study finds
Investigators explore how blinking rates synchronize with varying tempo rates—and the corresponding brain wave connection.
Events
Eyes On 2026 surpasses attendance expectations
The largest virtual eyecare event of the year showcased the next year of eyecare excellence for clinical professionals across the globe.
Research
Essilor Stellest 2.0 lenses demonstrate superior efficacy in slowing myopia progression
Upgraded FDA-authorized spectacle lenses for pediatric myopia control found to slow axial elongation more effectively after 1 year with advanced technology.
Research
Study identifies key vitamin supplementation for NCP
Vitamins B3, 12, and D may offer new therapeutic approaches to neuropathic corneal pain management.
Research